Abstract: The present invention relates to oil-in-water emulsion compositions useful for imparting an artificial tan to human skin. These emulsions contain paucilamellar lipid vesicles, i.e. vesicles comprising several concentric lipid bilayers, encapsulating an aqueous dihydroxyacetone solution. The vesicles comprise a polyoxyalkylene alkyl ether, a sterol, a quaternary ammonium compound, and optionally, a non-surface active oil. In further embodiments, these emulsion compositions contain one or more sunscreens, and are also useful for protecting human skin from the harmful effects of sunlight and other sources of ultraviolet radiation. The present invention also relates to methods for preparing these compositions, methods for providing an artificial tan to human skin, and methods for protecting human skin from the harmful effects of ultraviolet radiation.

Abstract: Disclosed are sunscare compositions having enhanced substantivity, efficacy and the like for protecting the skin from the harmful effects of ultraviolet irradiation, such as sunburn and sun-induced premature aging of the skin.

Abstract: Novel antitussive and anesthetic liquid compositions of matter for oral use comprising an effective oral antitussive drug and dyclonine; and method of using same.

Abstract: The present invention relates to sunscreen compositions for substantially daily use containing effective sunscreening agents for both UVA and UVB radiation which are not readily absorbed by the skin; which have increased sunscreen protection and decreased chance for allergy, irritation, or toxicity problems resulting from daily or almost daily use; and which are less susceptible to rub off. These sunscreen compositions provide a constant and even protection against both UVA and UVB radiation and which are cosmetically acceptable. Furthermore, the present invention relates to methods for protecting the skin of humans or lower animals from the effects of UVA and UVB wavelength radiation. This method comprises topically applying to the skin on a substantially daily basis an effective coating of a sunscreen composition of the present invention.

Abstract: Disclosed are leave-on facial emulsion compositions that are substantially free from fats and oils and anionic surfactants, which provide improved control of sebum distribution over the surface of the skin. These compositions provide improved cosmetic benefits in terms of the control of the undesirable appearance and tactile sensation of oily skin.

Abstract: Disclosed are leave-on facial emulsion compositions that are substantially free from fats and oils and anionic surfactants, which provide improved control of sebum distribution over the surface of the skin. These compositions provide improved cosmetic benefits in terms of the control of the undesirable appearance and tactile sensation of oily skin.

Abstract: Disclosed are stabilizer compositions comprising specific mixed partial salts of a lower alkyl vinyl ether-maleic acid copolymer wherein said partial salts contain as the cationic salt function:(a) from about 10% to about 65% zinc or strontium cations; and(b) from about 10% to about 75% calcium cationsof the total initial carboxyl groups reacted. Also disclosed are denture stabilizing compositions comprising these mixed partial salts, as well as denture stabilizing compositions comprising a safe and adhesively effective amount of two or more denture adhesive components wherein one of said denture adhesive components is the mixed partial salt(s) of the present invention.

Abstract: Denture cleansing tablet comprising an inorganic persalt bleaching agent, an organic peroxyacid bleach precursor and a solid base material which in the presence of water releases carbon dioxide with effervescence. The composition provides more rapid and efficaceous denture cleansing performance and anti-bacterial activity.

Abstract: Disclosed are oral anesthetic pharmaceutical compositions comprising: (a) from about 0.02% to about 25% of a pharmaceutically acceptable acid salt of a .beta.-aminopropiophenone, such as dyclonine HCl; (b) from about 0.02% to about 20% of saccharin; and (c) from about 1% to about 99% of a pharmaceutically acceptable oral carrier. Also provided are methods for providing an anesthetic effect in humans or animals which comprises orally administering to said human or animal a safe and effective amount of these pharmaceutical compositions. Also provided is a novel process for the manufacture of anesthetic lozenges containing a .beta.-aminopropiophenone along with saccharin.

Abstract: The present invention relates to emulsion compositions and methods for preparing these emulsion compositions which employ amphipathic emulsifying agents and high shear polymeric emulsion techniques and which may be used for the preparation of a great variety of emulsion compositions. In particular, the method provides for the preparation of hybrid products which effectively cleanse and also leave a highly protective substantive residue on the skin.

Abstract: Disclosed are facial cleansing compositions in the form of an oil-in-water emulsion which contain specific surfactants with an HLB above about 10 in combination with specific polyalphaolefins and specific carboxylic copolymers which provide improved cleansing efficacy as well as improved rinsability and improved skin feel (such as a nongreasy feeling).

Abstract: Disclosed are oral pharmaceutical preparations which comprise a pharmacologically active drug bound to small particles of an ion-exchange resin to provide a drug-resin complex having a drug content above a specified value. The drug-resin complex is subsequently coated with a water-permeable diffusion barrier coating that is insoluble in gastrointestinal fluids thereby providing a controllable sustained release of drug under conditions encountered in the gastrointestinal tract.

Abstract: Novel pharmaceutical compositions of matter are provided comprising analgesic/non-steroidal anti-inflammatory drugs and diphenhydramine and methods of using said compositions to elicit an enhanced analgesic and/or anti-inflammatory response in mammalian organisms in need of such treatment.

Abstract: Skin treatment compositions are provided which inhibit generation of free radicals in the skin and which include 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, 6-ethoxy-1,2-dihydro-2,3,4-trimethyl quinoline or mixture thereof, and optionally a stabilizer for the 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid which is monoethanolamine sulfite or sodium bisulfite.

Abstract: An oil-in-water-in-silicone fluid (o/w/s) emulsion composition comprising (a) a silicone fluid continuous phase, (b) an aqueous discontinuous phase comprising an oil-in-water (o/w) emulsion, and (c) an effective dispersing amount of dimethicone copolyol for dispersing (b) in (a).

Abstract: Disclosed are oral anesthetic pharmaceutical compositions comprising: (a) from about 0.02% to about 25% of a pharmaceutically acceptable acid salt of a .beta.-aminopropiophenone, such as dyclonine HCl; (b) from about 0.02% to about 20% of saccharin; and (c) from about 1% to about 99% of a pharmaceutically acceptable oral carrier. Also provided are methods for providing an anesthetic effect in humans or animals which comprises orally administering to said human or animal a safe and effective amount of these pharmaceutically compositions. Also provided is a novel process for the manufacture of anesthetic lozenges containing a .beta.-aminopropiophenone along with saccharin.

Abstract: Novel pharmaceutical compositions of matter are disclosed for use in eliciting a topical anesthetic and antimicrobial response, preferably for oral health care purposes, said compositions comprising dyclonine hydrochloride and phenol. When used in combination, dyclonine hydrochloride and phenol provide an improved antimicrobial response.

Abstract: Disclosed are wax based cosmetic stick compositions comprising: from about 10% to about 50% of a wax type solidifying agent; and from about 5% to about 90% of a polyalphaolefin. These compositions preferably comprise from about 1.0% to about 40% of an active component, such as a sunscreen agent, analgesic, moisturizing and antiperspirant or a deodorant active.

Abstract: Novel pharmaceutical compositions of matter are provided comprising analgesic/non-steroidal anti-inflammatory drugs and diphenhydramine and methods of using said compositions to elicit and enhanced analgesic and/or anti-inflammatory response in mammalian organisms in need of such treatment.

Abstract: Novel antitussive and anesthesic liquid compositions of matter for oral use comprising an effective oral antitussive drug and phenol, and method of using same.